
New NIH grant supports development of experimental pediatric HIV vaccine
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. A successful vaccine to prevent new HIV infections would be a major…